Abivax S.A. ( ABVX) - Key Metrics
ABVX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q2 | $0.03 | -$1.59 | -$1.05 | -$1.05 |
| 2024Q4 | $0.06 | -$1.50 | -$1.11 | -$1.12 |
| 2024Q2 | $0.11 | -$1.30 | -$1.35 | -$1.36 |
| 2023Q4 | $0.04 | -$1.91 | -$1.38 | -$1.39 |
ABVX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q2 | ? | -1.04 |
| 2024Q4 | ? | -1.13 |
| 2024Q2 | ? | -2.47 |
| 2023Q4 | ? | -1.29 |
ABVX
Price: $99.44
52 week price:
Earnings Per Share: -5.36 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.9 billion